1996
DOI: 10.1002/hlca.19960790508
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, Conformational Properties, and Synthetic Applications of Novel Optically Pure α,α‐Disubstituted (R)‐ and (S)‐Glycines (‘α‐Chimeras’) Combining Side Chains of Asp, Glu, Leu, Phe, Ser, and Val

Abstract: ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
6
0
1

Year Published

1997
1997
2013
2013

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 41 publications
(7 citation statements)
references
References 34 publications
0
6
0
1
Order By: Relevance
“…A large body of other chiral C α ‐tetrasubstituted α‐amino acids (Figure 12) has been synthesized, and the conformational preference of some of their derivatives and very short peptides analyzed by experiments and/or computations 68, 221–245. However, since the examples are scattered, the model compounds are not always appropriately selected, and in general they are too short, in our view it is undoubtedly premature to extract any definitive conclusion from these studies.…”
Section: Discussionmentioning
confidence: 99%
“…A large body of other chiral C α ‐tetrasubstituted α‐amino acids (Figure 12) has been synthesized, and the conformational preference of some of their derivatives and very short peptides analyzed by experiments and/or computations 68, 221–245. However, since the examples are scattered, the model compounds are not always appropriately selected, and in general they are too short, in our view it is undoubtedly premature to extract any definitive conclusion from these studies.…”
Section: Discussionmentioning
confidence: 99%
“…For instance, introduction of succinimides 1 in peptidomimetics results in a high preference for b-turn type-II/type-II' conformations. [3,4] Related N-mesyloxysuccinimides 2 behave as irreversible mechanism-based inhibitors of serine proteases. [5] Of particular value is Ranirestat (AS-3201) which is an aldose reductase inhibitor currently in the final stage of clinical phase III trials.…”
mentioning
confidence: 99%
“…Beispielsweise führt der Einbau von Succinimiden 1 in Peptidmimetika zu einer hohen Präferenz für bSchleifen mit Typ-II/-II'-Konformationen. [3,4] Verwandte NMesyloxysuccinimide 2 wirken als irreversible mechanismusbasierte Inhibitoren von Serinproteasen. [5] Von besonderem Wert ist zudem Ranirestat (AS-3201), ein Aldosereductase-Inhibitor, der sich gegenwärtig im finalen Stadium von klinischen Phase-III-Studien befindet.…”
unclassified